If I was a shareholder, I'd be feeling pretty lucky that Pfizer have locked in 14.5c takeover offer.
Thise results are very mediocre, and use case with regard to Covid is dwindling.
Seems like Pfizer got a poor deal, but great for RAP shareholders.
- Forums
- ASX - By Stock
- RAP
- Ann: Results from Data Confirmation Study
Ann: Results from Data Confirmation Study, page-10
-
- There are more pages in this discussion • 416 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug